Literature DB >> 19237090

Descriptive epidemiology of chronic hepatitis B by using data from a hepatitis registry in Central Greece.

Aggelos Stefos1, Nikolaos Gatselis, Kalliopi Zachou, Eirini Rigopoulou, Christos Hadjichristodoulou, George N Dalekos.   

Abstract

BACKGROUND: In Greece, there are few data on the epidemiological characteristics of HBV. Our aim was to study the epidemiological patterns of HBV in Central Greece and identify the possible differences in HBV prevalence (clusters) among areas inside this region using data from the hepatitis registry.
METHODS: The study was performed in Thessaly, one out of the thirteen regions of Greece and covers most of the part of Central Greece. A total of 921 HBV patients were registered in the hepatitis registry during the period 1999-2004 while 303 were randomly selected to be studied further using a detailed questionnaire on several epidemiological factors.
RESULTS: 187/303 patients (61.7%) classified as chronic inactive HBV carriers, 78/303 (25.7%) had chronic hepatitis B, 29/303 (9.6%) had HBV-related cirrhosis and 9/303 (3%) HBV-related hepatocellular carcinoma (HCC). The route of HBV transmission was vertical in 103 (34%), sexual in 46 (15.1%) and intrafamilial in 98 (32.4%). Folk remedies were identified as the predisposing risk factor for contracting HBV infection in 38 (12.5%), previous transfusion in 9 (3%) and unknown mode of transmission in 9 patients (3%). Alcohol abuse was the only independent factor (OR: 2.5; p=0.01) associated with the progression to cirrhosis-HCC. There were specific areas (clusters) inside Thessaly region with increased ratio of HBV infection; Vertical and sexual modes of transmission were more prominent in some of these areas.
CONCLUSIONS: Vertical, intrafamilial and sexual modes of HBV transmission identified as the major routes of HBV infection in our study. We also identified cluster areas of HBV infection in Central Greece. Alcohol abuse is frequent among HBV patients and is acting as an effect modificator risk factor for the development of HBV-related cirrhosis and HCC. Extended population studies in Greece are needed to assess in detail the epidemiological patterns of HBV and evaluate control programmes.

Entities:  

Mesh:

Year:  2008        PMID: 19237090     DOI: 10.1016/j.ejim.2008.04.023

Source DB:  PubMed          Journal:  Eur J Intern Med        ISSN: 0953-6205            Impact factor:   4.487


  8 in total

1.  Primary biliary cirrhosis in HBV and HCV patients: Clinical characteristics and outcome.

Authors:  Eirini I Rigopoulou; Kalliopi Zachou; Nikolaos K Gatselis; Georgia Papadamou; George K Koukoulis; George N Dalekos
Journal:  World J Hepatol       Date:  2013-10-27

2.  Cartilage oligomeric matrix protein: A novel non-invasive marker for assessing cirrhosis and risk of hepatocellular carcinoma.

Authors:  Gary L Norman; Nikolaos K Gatselis; Zakera Shums; Christos Liaskos; Dimitrios P Bogdanos; George K Koukoulis; George N Dalekos
Journal:  World J Hepatol       Date:  2015-07-18

3.  Three decades of hepatitis B control with vaccination.

Authors:  Liliane C Meireles; Rui Tato Marinho; Pierre Van Damme
Journal:  World J Hepatol       Date:  2015-08-28

4.  Prevalence of occult hepatitis B virus infection in haemodialysis patients from central Greece.

Authors:  Paraskevi Mina; Sarah P Georgiadou; Christos Rizos; George N Dalekos; Eirini I Rigopoulou
Journal:  World J Gastroenterol       Date:  2010-01-14       Impact factor: 5.742

5.  The changing epidemiology of hepatitis B in Greece.

Authors:  Eirini I Rigopoulou; Nikolaos K Gatselis; Konstantinos Galanis; Vasiliki Lygoura; Stella Gabeta; Kalliopi Zachou; George N Dalekos
Journal:  Ann Gastroenterol       Date:  2021-02-26

6.  Ocular disorders as the prevailing manifestations of antiphospholipid syndrome: a case series.

Authors:  Evangelia Tsironi; Nikolaos Gatselis; Maria G Kotoula; Kalliopi Zachou; Maria Pefkianaki; Fani Zacharaki; Dimitrios Z Chatzoulis; George N Dalekos
Journal:  Cases J       Date:  2009-10-20

7.  Golgi protein-73: A biomarker for assessing cirrhosis and prognosis of liver disease patients.

Authors:  Nikolaos K Gatselis; Tamás Tornai; Zakera Shums; Kalliopi Zachou; Asterios Saitis; Stella Gabeta; Roger Albesa; Gary L Norman; Mária Papp; George N Dalekos
Journal:  World J Gastroenterol       Date:  2020-09-14       Impact factor: 5.742

8.  Estimating the proportion of people with chronic hepatitis B virus infection eligible for hepatitis B antiviral treatment worldwide: a systematic review and meta-analysis.

Authors:  Mingjuan Tan; Ajeet S Bhadoria; Fuqiang Cui; Alex Tan; Judith Van Holten; Philippa Easterbrook; Nathan Ford; Qin Han; Ying Lu; Marc Bulterys; Yvan Hutin
Journal:  Lancet Gastroenterol Hepatol       Date:  2020-11-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.